Influenza vaccination can induce new-onset anticardiolipins but not β2-glycoprotein-I antibodies among patients with systemic lupus erythematosus

Lupus

Volumn 21, Issue 2, 2012, Pages 168-174

  Vista, E S ^a,b   Crowe, S R ^a   Thompson, L F ^a   Air, G M ^c   Robertson, J M ^a   Guthridge, J M ^a   James, J A ^a,c  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF SANTO TOMAS HOSPITAL   (Philippines)

^c UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

antiphospholipid antibodies; influenza; systemic lupus erythematosus; vaccine

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; INFLUENZA VACCINE; PHOSPHOLIPID ANTIBODY;

ADULT; AFRICAN AMERICAN; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFECTION PREVENTION; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; SEASONAL INFLUENZA; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTICARDIOLIPIN; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; CARDIOLIPINS; FEMALE; GLYCOPROTEINS; HUMANS; INFLUENZA VACCINES; LUPUS COAGULATION INHIBITOR; LUPUS ERYTHEMATOSUS, SYSTEMIC; VACCINATION;

EID: 84855758517     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203311429554     Document Type: Article

References (42)

1. Hughes G. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J (Clinc Res Ed). 1983 ; 287: 1088-1089 (Pubitemid 13011933)
2. Harris E, Chan J, Asherson R, Aber V, Gharavi A, Hughes G. Thrombosis, recurrent fetal loss, and thrombocytopenia. Predicitive value of the anticardiolipin antibody test. Arch Intern Med. 1986 ; 146: 2153-2156 (Pubitemid 17189088)
3. Harris E, Gharavi A, Boey M, et al. Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet. 1983 ; 322: 1211-1214 (Pubitemid 14229783)
4. Hughes G. Hughes syndrome: antiphospholipid syndrome. J R Coll Physicians Lond. 1998 ; 32: 260-264
5. Hochberg M. Updating the American College of Rheumatology Revised Criteria for the Classification of Systemic Lupus Erythematosus. Arthritis Rheum. 1997 ; 40: 1725-1725
6. Somers E, Magder L, Petri M. Antiphospholipid antibodies and incidence of venous thrombosis in a cohort of patients with systemic lupus erythematosus. J Rheumatol. 2002 ; 29: 2531-2536 (Pubitemid 35416957)
7. Tektonidou M, Laskari K, Panagiotakos D, Moutsopoulos H. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Arthritis Rheum. 2009 ; 61: 29-36
8. McClain MT, Arbuckle MR, Heinlen LD, et al. The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. Arthritis Rheum. 2004 ; 50: 1226-1232 (Pubitemid 38480833)
9. Tsutsumi A, Matsuura E, Ichikawa K, et al. Antibodies to beta 2-glycoprotein 1 and clinical manifestiations in patients with systemic lupus erythematosus. Arthritis Rheum. 1996 ; 39: 1466-1474 (Pubitemid 26314979)
10. Amengual O, Atsumi T, Khamashta M, Koike T, Hughes G. Specificity of ELISA for antibody to beta 2-glycoprotein I in patients with antiphospholipid syndrome. Br J Rheumatol. 1996 ; 35: 1239-1243
11. Koike T, Matsuura E. Anti-beta 2-glycoprotein 1 antibody: specificity and clinical significance. Lupus. 1996 ; 5: 378-380 (Pubitemid 26354049)
12. Miyakis S, Lockshin M, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 ; 4: 295-306
13. Espinosa G, Cervera R. Antiphospholipid syndrome: frequency, main causes, and risk factors of mortality. Nat Rev Rheumatol. 2010 ; 6: 296-300
14. Asherson R, Cervera R, Piette J, et al. Catastrophoic antiphospholipid syndrome: Clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore). 2001 ; 80: 355-377 (Pubitemid 33070843)
15. James J, Scofield R, Harley J. Lupus humoral autoimmunity after short peptide immunization. Ann N Y Acad Sci. 1997 ; 815: 124-127 (Pubitemid 27309498)
16. Molina V, Shoenfeld Y. Infection, vaccines, and other environmental triggers of autoimmunity. Autoimmunity. 2005 ; 38: 235-245 (Pubitemid 40959897)
17. Orbach H, Agmon-Levin N, Zandman-Goddard G. Vaccines and autoimmune diseases of the adult. Discov Med. 2010 ; 9: 90-97
18. James J, Harley J, Scofield R. Epstine-Barr virus and systemic lupus erythematosus. Curr Opin Rheumatol. 2006 ; 18: 462-467 (Pubitemid 44200328)
19. Santiago M, Cossermelli W, Tuma M, Pinto M, Oliveira R. Anticardiolipin antibodies in patients with infectious disease. Clin Rheumatol. 1986 ; 8: 23-28
20. Vaarala P, Palosuo T, Kleemola M, Aho K. Anticardiolipin response in acute infections. Clin Immunol Immunopathol. 1986 ; 41: 8-15 (Pubitemid 16014463)
21. Crowe SR, Merrill JT, Vista ES, et al. Influenza vaccination responses in human systemic lupus erythematosus: impact of clinical and demographic features. Arthritis Rheum 2011; 63: 2396-2406.
22. Kirkman T. Statistics to use. http://www.physics.csbsju.edu/stats/ (1996, consulted October 2010)..
23. Gharavi A, Peirangeli S, Espinola R, Liu X, Colden-Stanfield M, Harris E. Antiphospholipid antibodies induced in mice by immunization with cytomegalovirus-derived peptide cause thrombosis and activation of endothelial cells in vivo. Arthritis Rheum. 2002 ; 46: 545-552 (Pubitemid 34136593)
24. Blank M, Krause I, Fridkin M, et al. Bacterial induction of autoantibodies to B2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome. J Clin Invest. 2002 ; 109: 797-804 (Pubitemid 34263156)
25. Martinuc Porobic J, Avcin T, Bozic B, et al. Anti-phospholipid antibodies following vaccination with recombinant hepatitis B vaccine. Clin Exp Immunol. 2005 ; 142: 377-380 (Pubitemid 41565256)
26. Toplak N, Kveder T, Trampus-Bakija A, Subelj V, Cucnik S, Avcin T. Autoimmune response following annual influenza vaccination in 92 apparently healthy adults. Autoimmun Rev. 2008 ; 8: 134-138
27. Mormile R, D'Alterio V, Treccagnoli G, Sorrentino P. Henoch-Schonlein purpura with antiphospholipid antibodies after influenza vaccination: how fearful is it in children?. Vaccine. 2004 ; 23: 567-568 (Pubitemid 39473184)
28. Watanabe T, Onda H. Henoch-Schonlein purpura with antiphospholipid antibodies following an influenza vaccination. Pediatr Nephrol. 2001 ; 16: 458-459 (Pubitemid 32447712)
29. Elkayam O, Paran D, Burke M, et al. Pneumococcal vaccination of patients with systemic lupus erythematosus: effects on generation of autoantibodies. Autoimmunity. 2005 ; 38: 493-496 (Pubitemid 43101783)
30. Abu-Shakra M, Press J, Sukenik S, Buskila D. Influenza virus vaccination of patients with SLE: Effects on generation of autoantibodies. Clin Rheumatol. 2002 ; 21: 369-372
31. Tarjan P, Sipka S, Lakos G, Kiss E, Ujj G, Szegedi G. Influenza vaccination and the production of anti-phospholipid antibodies in patients with systemic lupus erythematosus. Scand J Immunol. 2006 ; 35: 241-243 (Pubitemid 43890747)
32. Hunt J, McNeil H, Morgan G, Crameri R, Krilis S. A phospholipid-beta 2-glycoprotein I complex in an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection. Lupus. 1992 ; 1: 75-81
33. Cabral A, Cabiedes J, Alarcon-Segovia D. Heterogeneity of antibodies to beta 2-glycoprotein 1 from patients with systemic lupus erythematosus. Lupus. 2004 ; 13: 182-187 (Pubitemid 38478645)
34. Matsuura E, Igarashi Y, Fujimoto M, et al. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol. 1992 ; 148: 3885-3891
35. Matsuura E, Shen L, Matsunami Y, et al. Pathophysiology of beta2-glycoprotein I in antiphospholipid syndrome. Lupus. 2010 ; 19: 379-384
36. Nakaya Y, Schaefer E, Brewer Jr H. Activation of human post heparine lipoprotein lipase by apolipoprotein H (beta 2-glycoprotein I). Biochem Biophys Res Commun. 1980 ; 95: 1168-1172 (Pubitemid 10017406)
37. George J, Gilburd B, Hojnik M, et al. Target recognition of B2-glycoprotein I (B2GPI)-dependent anticardiolipin antibodies: evidence for involvement of the fourth domain of B2GPI in antibody binding. J Immunol. 1998 ; 160: 3917-3923 (Pubitemid 28176098)
38. de Laat B, de Groot P. Autoantbodies directed against domain I of beta 2-glycoprotein I. Curr Rheumatol Rep. 2011 ; 13: 70-76
39. Cervera R, Asherson R. Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics. Immunobiology. 2005 ; 210: 735-741 (Pubitemid 41683856)
40. Rauch J, Dieude M, Saubang R, Levine J. The dual role of innate immunity in the antiphospholipid syndrome. Lupus. 2010 ; 19: 347-353
41. Abu-Shakra M. Safety of vaccination of patients with systemic lupus erythematosus. Lupus. 2009 ; 18: 1205-1208
42. Abu-Shakra M, Zalmanson S, Neumann L, Flusser D, Sukenik S, Buskila D. Influenza virus vaccination of patients with systemic lupus erythematosus: effects on disease activity. J Rheumatol. 2000 ; 27: 1681-1685 (Pubitemid 30462811)